BTR Capital Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $655K | Hold |
13,140
| – | – | 0.1% | 99 |
|
|
2022
Q2 | $732K | Hold |
13,140
| – | – | 0.11% | 97 |
|
|
2022
Q1 | $730K | Hold |
13,140
| – | – | 0.09% | 100 |
|
|
2021
Q4 | $736K | Hold |
13,140
| – | – | 0.08% | 106 |
|
|
2021
Q3 | $631K | Hold |
13,140
| – | – | 0.08% | 107 |
|
|
2021
Q2 | $550K | Hold |
13,140
| – | – | 0.07% | 113 |
|
|
2021
Q1 | $443K | Hold |
13,140
| – | – | 0.06% | 120 |
|
|
2020
Q4 | $459K | Sell |
13,140
-2,500
| -16% | -$86.4K | 0.07% | 112 |
|
|
2020
Q3 | $543K | Sell |
15,640
-1,000
| -6% | -$33.3K | 0.1% | 101 |
|
|
2020
Q2 | $545K | Hold |
16,640
| – | – | 0.1% | 100 |
|
|
2020
Q1 | $501K | Hold |
16,640
| – | – | 0.11% | 100 |
|
|
2019
Q4 | $482K | Hold |
16,640
| – | – | 0.08% | 113 |
|
|
2019
Q3 | $430K | Hold |
16,640
| – | – | 0.08% | 116 |
|
|
2019
Q2 | $425K | Hold |
16,640
| – | – | 0.08% | 119 |
|
|
2019
Q1 | $435K | Hold |
16,640
| – | – | 0.08% | 113 |
|
|
2018
Q4 | $383K | Sell |
16,640
-782
| -4% | -$17.4K | 0.08% | 122 |
|
|
2018
Q3 | $411K | Buy |
17,422
+782
| +5% | +$19.1K | 0.07% | 115 |
|
|
2018
Q2 | $384K | Hold |
16,640
| – | – | 0.07% | 103 |
|
|
2018
Q1 | $410K | Hold |
16,640
| – | – | 0.08% | 102 |
|
|
2017
Q4 | $447K | Hold |
16,640
| – | – | 0.09% | 102 |
|
|
2017
Q3 | $401K | Hold |
16,640
| – | – | 0.08% | 106 |
|
|
2017
Q2 | $357K | Hold |
16,640
| – | – | 0.07% | 116 |
|
|
2017
Q1 | $285K | Sell |
16,640
-468
| -3% | -$8.15K | 0.06% | 126 |
|
|
2016
Q4 | $356K | Hold |
17,108
| – | – | 0.08% | 125 |
|
|
2016
Q3 | $356K | Sell |
17,108
-232
| -1% | -$5.75K | 0.08% | 125 |
|
|
2016
Q2 | $466K | Hold |
17,340
| – | – | 0.11% | 114 |
|
|
2016
Q1 | $470K | Sell |
17,340
-100
| -0.6% | -$2.68K | 0.11% | 112 |
|
|
2015
Q4 | $506K | Sell |
17,440
-100
| -0.6% | -$2.77K | 0.12% | 119 |
|
|
2015
Q3 | $476K | Sell |
17,540
-300
| -2% | -$8.49K | 0.11% | 115 |
|
|
2015
Q2 | $488K | Sell |
17,840
-800
| -4% | -$22.5K | 0.11% | 104 |
|
|
2015
Q1 | $498K | Sell |
18,640
-1,450
| -7% | -$33.4K | 0.12% | 104 |
|
|
2014
Q4 | $425K | Sell |
20,090
-1,100
| -5% | -$24.6K | 0.12% | 95 |
|
|
2014
Q3 | $505K | Sell |
21,190
-700
| -3% | -$16.1K | 0.14% | 89 |
|
|
2014
Q2 | $506K | Sell |
21,890
-500
| -2% | -$11K | 0.14% | 90 |
|
|
2014
Q1 | $511K | Sell |
22,390
-200
| -0.9% | -$4.26K | 0.15% | 91 |
|
|
2013
Q4 | $417K | Sell |
22,590
-3,650
| -14% | -$63.6K | 0.12% | 99 |
|
|
2013
Q3 | $444K | Sell |
26,240
-7,200
| -22% | -$121K | 0.14% | 95 |
|
|
2013
Q2 | $518K | Buy |
+33,440
| New | +$557K | 0.16% | 93 |
|
Other funds holding NVO
F
BTR Capital Management's NVO Position: Q3 2022 in Review
BTR Capital Management held its Novo Nordisk (NVO) position steady in Q3 2022 at 13,140 shares worth $655K. The position accounts for 0.1% of the portfolio, ranked #99.
BTR Capital Management first reported a position in NVO in Q2 2013 and has held it in 38 quarters since. The position peaked at $736K in Q4 2021. 908 funds tracked by Wall St. Rank hold NVO as of Q3 2022.
- BTR Capital Management held 13,140 shares of Novo Nordisk worth $655K as of Q3 2022.
- BTR Capital Management left its Novo Nordisk share count unchanged in Q3 2022.
- Novo Nordisk made up 0.1% of BTR Capital Management's portfolio in Q3 2022, its #99 holding.
- BTR Capital Management first reported a position in Novo Nordisk in Q2 2013 and has held it in 38 quarters since.
- BTR Capital Management's Novo Nordisk position peaked at $736K in Q4 2021.
- 908 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2022.
Based on BTR Capital Management's 13F filing for Q3 2022, filed 12 Oct 2022.